Xintela AB (publ)
Greg Batcheller is an accomplished executive with extensive experience in leadership roles across various companies. Currently serving as Chairman at Intellego Technologies AB, Edvince AB, Targinta AB, Xintela AB, Stanbridge Corporation, and CarryGenes Group, Greg Batcheller also holds the position of Director at Business Research Life Sciences Ltd and has served as a director for Canacyl AB and Pharmacyl AB. An active board member at SAGA Dx Inc, with a significant background in law and international relations, Greg Batcheller earned a B.Sc. in Economics from The London School of Economics and Political Science, an LL.M. in European Union Law from Lund University, and a JD from the University of Toronto.
This person is not in any teams
This person is not in any offices
Xintela AB (publ)
2 followers
Xintela AB (publ), a biomedical company, operates in the fields of regenerative medicine and cancer, focusing on cartilage damage.